BCR-ABL tyrosine kinase inhibitors

BMS 140 857 Pill - white round, 11mm

Generic Name: dasatinib

Pill with imprint BMS 140 857 is White, Round and has been identified as Sprycel 140 mg. It is supplied by Bristol-Myers Squibb.

Sprycel is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sprycel (Dasatinib [ da-sat-in-ib ])-BMS 140 857-140 mg-White-Round
Sprycel (Dasatinib [ da-sat-in-ib ])-BMS 140 857-140 mg-White-Round

Sprycel
Generic Name: dasatinib [ da-sat-in-ib ]
Imprint: BMS 140 857
Strength: 140 mg
Color: White
Size: 11.00 mm
Shape: Round
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00003-0857
Inactive Ingredients: Lactose monohydrate, Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Titanium dioxide,
Latest News
Related Drugs